Micron Reportedly Surpasses 1 Trillion Market Cap Amid Unprecedented Support from Trump and Wall Street Piccadily Agro Industries Sets Sights on 40 International Revenue Share via Global Expansion Tesla Delivers Mixed Q1 Revenue Miss Profit Beat as Auto Margins Strengthen Cancer Treatment Costs Surge ACA May Offer Limited Relief Amid Rising Expenses China Urges APEC Cooperation as Commerce Minister Skipped Opening Over Urgent Official Business Egypts Landmark Gas Discoveries Signal Upstream Revival Yet Import Challenges Remain OMC Q1 2026 Earnings EPS Surpasses Estimates Amid Mixed Market Dynamics GNTX Q1 2026 Earnings EPS Beats Estimates with 381 Surprise as Shares Dip Slightly PODD Q1 2026 Earnings Strong EPS Beat Overshadowed by Tepid Market Response DUOT Q1 2026 Earnings Wide EPS Miss Fails to Dampen Investor Sentiment AMWD Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency TLPH Q1 2026 Earnings Significant EPS Beat as PreRevenue Biotech Advances Pipeline Oxford Lane Capital Preferred Shares OXLCP Hold Steady Near Resistance After Modest Gain ENI E Edges Higher Amid Cautious Trading Key Levels in Focus Fifth Third Bancorp FITB Holds Steady Near Support as Consolidation Persists MACOM Technology Solutions MTSI Shares Decline 258 as Tech Sector Headwinds Persist BlackRock Municipal 2030 Target Term Trust BTT Inches Higher as Investors Seek TaxExempt Stability SII Q1 2026 Earnings EPS Surprises Upward Despite Broader Market Headwinds AMWL Q1 2026 Earnings EPS Beats Estimates by Wide Margin as Cost Controls Drive Improvement Lightwave Logic Inc LWLG Q3 2024 Earnings Continued RD Progress Amid PreRevenue Phase Janus International Group Inc JBI Q1 2026 Earnings EPS Misses Estimates Stock Edges Higher Despite Weak Results ENB Q1 2026 Earnings EPS Beat by 306 Despite Broader Market Headwinds PRM Q1 2026 Earnings EPS Surges 197 Above Estimates but Stock Declines MidMarket PE Fundraising Recovery May Not Be Enough for Smaller Managers Lamb Weston LW Q1 2026 Earnings EPS Surpasses Estimates as Shares Gain Ground Armata Pharmaceuticals ARMP Edges Higher Stock Holds Near Key Resistance After Modest Gain